Haraguchi et al. reported that the CD133+ CD44+ population may be the real cancer initiating cells of human colorectal cancer [44] while Dalerba et al. found that most CD44+ cells are also CD133+, suggesting that CD44+ is an adequate marker for CSC in colorectal cancer [52]. The gene discussed is CD44; the disease is cancer.